Following the review of around 20 candidate vaccines by the external advisory group, MVC's vaccine was selected as one of two to be included in the global trial
Dr Lal PathLabs revenue contribution from west India to go up from 10% to 24% post-acquisition basis FY21
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
It answers the most basic questions from a patient’s perspective
FDI increased 98% year on year in 2020 and pharma exports grew by 18% in the last financial year
Filing marks first protein-based vaccine submitted to MHRA for authorization
The list of kids with co-morbidities eligible for vaccination would be announced by the government
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
Collaboration designed to bring reproductive health screening capabilities to hospitals and clinics across the country
Expands wound care portfolio and aims to drive greater market penetration and availability in the wound dressing category
Subscribe To Our Newsletter & Stay Updated
